Financials
- Market Capitalization 2.6 B
- Employee 252
- Founded 2010
- CEO N/A
- Website www.viridiantherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG002H242Z5
- Industry 生物工学
総売上高
当期純利益
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-3.71
売上高対価格比率
—
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 1814 | NRIX Nurix Therapeutics, Inc. - Common stock | 25.32 USD | -1.94% | -4.52% | +2.06% | +125.87% | 2.63 B USD | ||
| 1817 | NKTR Nektar Therapeutics - Common Stock | 76.37 USD | +4.99% | +3.19% | +3.82% | +4.23% | 2.61 B USD | ||
| 1829 | BCRX BioCryst Pharmaceuticals, Inc. - Common Stock | 10.09 USD | -0.79% | +2.75% | +6.89% | +22.01% | 2.58 B USD | ||
| 1834 | PGEN Precigen, Inc. - Common Stock | 7.14 USD | +1.85% | +0.42% | +1.13% | +54.21% | 2.56 B USD |